Holen Sie sich die Stockscreener-App
23.19
0.04%
0.01
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Does Collegium Pharmaceutical (COLL) Have the Potential to Rally 111.39% as Wall Street Analysts Expect? - Zacks Investment Research
Amneal Pharmaceuticals, Inc. (AMRX) stock price, news, quote and history - Yahoo Finance Singapore
Four investors report shared voting power over Collegium Pharma (COLL) shares. - Stock Titan
New Strong Sell Stocks for October 7th - Zacks Investment Research
An estimated 15.5 million U.S. adults have ADHD. Three guides help families navigate care and school. - Stock Titan
Oppenheimer sets USD 50.00 target for Collegium Pharmaceutical stock - AD HOC NEWS
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Former officer Scott Dreyer proposes selling 27,419 Collegium Pharmaceutical (COLL) shares. - Stock Titan
Amylyx Pharmaceuticals, Inc. (AMLX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Amylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance Australia
Oppenheimer initiates Collegium Pharmaceutical stock at Outperform - Investing.com
Leerink Partners Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $45 - Moomoo
COSCIENS ACQUIRES NUALTIS CORP. - The Manila Times
(COLL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical stock edges higher after recent quarterly update - ad-hoc-news.de
Collegium Pharmaceutical Inc. (COLL) Peer Comparison – Compare with Others - Value Research
(COLL) Risk Channels and Responsive Allocation - Stock Traders Daily
A Look at Collegium Pharmaceutical Inc (COLL) After 3.9% Decline -- GF Value $47.17 vs Price $26.39 - GuruFocus
Israel A. Englander reports new Collegium (NASDAQ: COLL) stake - Stock Titan
Collegium (COLL) Move: Ends Higher by 2.18% at $27.70 in Latest Trading; Technical View: the $26.31 to $29.09 Range Remains in Focus in the Latest SessionETF NAV Deviation - vinanet.vn
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $48 - Moomoo
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call - Yahoo Finance
Fuller & Thaler (NASDAQ: COLL) reports 5.03% beneficial stake in common stock - Stock Titan
COLLEGIUM PHARMACEUTICAL INC : NEEDHAM CUTS TARGET PRICE TO $46 FROM $56 - webull.com
Can Collegium Pharmaceutical (NASDAQ:COLL) Rebound From Its Yearly Low? - Kalkine Media
Collegium Pharmaceutical Initiates $50 Million Accelerated Share Buyback with Jefferies LLC - Kalkine Media
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Canada
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com India
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com South Africa
Why is Collegium Pharmaceutical stock climbing today? By Investing.com - Investing.com Canada
Why is Collegium Pharmaceutical stock climbing today? By Investing.com - Investing.com UK
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Australia
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Australia
Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com
Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com
Collegium Pharmaceutical Launches $50 Million Accelerated Share Repurchase Program - citybiz
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com South Africa
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Australia
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com India
Collegium gains on accelerated share buybacks (COLL:NASDAQ) - Seeking Alpha
Collegium Pharmaceutical to repurchase $50 million in stock - Investing.com
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Canada
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com UK
Collegium Pharmaceutical launches $50M accelerated share repurchase under $150M buyback program - TradingView
Collegium Announces $50 Million Accelerated Share Repurchase Program - GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year LowTime to Sell? - MarketBeat
Collegium Announces $50 Million Accelerated Share Repurchase Program - finance.yahoo.com
7.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):